デフォルト表紙
市場調査レポート
商品コード
1424065

マイコプラズマ検査市場、シェア、規模、動向、産業分析レポート:製品・サービス別、技術別、用途別、エンドユーザー別、地域別、セグメント別予測、2024年~2032年

Mycoplasma Testing Market Share, Size, Trends, Industry Analysis Report, By Product & Service (Assays, Kits, & Reagents, Instruments, Services); By Technique; By Application; By End User; By Region; Segment Forecast, 2024 - 2032

出版日: | 発行: Polaris Market Research | ページ情報: 英文 118 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
マイコプラズマ検査市場、シェア、規模、動向、産業分析レポート:製品・サービス別、技術別、用途別、エンドユーザー別、地域別、セグメント別予測、2024年~2032年
出版日: 2024年01月24日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界のマイコプラズマ検査市場規模は2032年までに29億964万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

マイコプラズマは細胞壁を持たない細菌の一種。主にヒトの呼吸器、泌尿器、生殖器に感染する可能性が高いです。厳しい規制の存在と消費者の安全性に対する懸念の高まりにより、製薬会社はマイコプラズマの検査を含む包括的な生物学的検査に力を入れるようになっています。

2023年にJournal of Microbiologyに掲載された研究では、マイコプラズマ・ジェニタリウムの検出における進歩の探求に焦点が当てられています。米国食品医薬品局(FDA)による分子ベースのアッセイの最近の認可により、診断検査は米国で広く採用されるようになり、もはや一部の検査室でしか利用できなくなった。このことは、マイコプラズマ市場の成長にプラスの影響を与えています。

抗菌薬耐性の出現は、医薬品やサービスにおけるマイコプラズマの存在を検査することを困難にし、それが耐性を判定する診断検査の開発に拍車をかけた。マイコプラズマは、研究段階から臨床開発まで含め、バイオ医薬品の製造段階でほとんど検出され、特定の疾患の治療における安全性と正確性を確認するためのマイコプラズマ検査の必要性を強調しています。

この分野における研究革新の進展と先進技術の採用が、マイコプラズマ検査市場の拡大を促進すると予想されます。例えば、2023年11月、QIAGENは、細胞・遺伝子治療、食品産業、製薬産業におけるポリメラーゼ連鎖反応技術の製品ラインを拡大するために、3つの新しいQIAcuityキットとソフトウェアのアップデートを発表しました。

製品の品質と安全性を高めるためにバイオ製薬企業が継続的に行っている拡大活動は、マイコプラズマ検査市場にプラスの影響を与えています。例えば、2023年11月、細菌から医薬品を守ることに特化した製薬研究所であるBioniqueは、この地域で急速に成長している細胞療法や遺伝子療法からの継続的な需要に対応するため、ニューヨーク州レイククリアに拠点を拡張しました。

マイコプラズマ検査市場レポートハイライト

アッセイ、キット、試薬セグメントは、すぐに検査できるキットの必要性から、今後数年間で最も高い成長が見込まれます。

市場セグメンテーション部門は、迅速な検査結果を提供できることから、最大の市場シェアを占めています。

細胞株検査セグメントは、バイオ医薬品生産の増加により、より大きな収益シェアを占めると予測されます。

アジア太平洋地域は、細胞治療と遺伝子治療における技術革新の高まりにより、予測期間中に最も速い成長を記録すると予測されています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のマイコプラズマ検査市場に関する洞察

  • マイコプラズマ検査 - 業界スナップショット
  • マイコプラズマ検査市場力学
    • 促進要因と機会
      • マイコプラズマ検出を探る調査が増加
      • マイコプラズマ関連の健康問題の発生率の増加
    • 抑制要因と課題
      • 新しいイノベーションを採用する際の研究者の抵抗
  • PESTLE分析
  • マイコプラズマ検査業界の動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界のマイコプラズマ検査市場、製品・サービス別

  • 主な調査結果
  • イントロダクション
  • アッセイ、キット、試薬
  • 機器
  • サービス

第6章 世界のマイコプラズマ検査市場、用途別

  • 主な調査結果
  • イントロダクション
  • 細胞株検査
  • ウイルス検査
  • 生産終了後の細胞検査

第7章 世界のマイコプラズマ検査市場、技術別

  • 主な調査結果
  • イントロダクション
  • NAT
  • ELISA
  • 染色
  • その他の技術

第8章 世界のマイコプラズマ検査市場、エンドユーザー別

  • 主な調査結果
  • イントロダクション
  • 製薬・バイオテクノロジー企業
  • 細胞バンクと研究所
  • 受託研究機関
  • 学術研究機関

第9章 世界のマイコプラズマ検査市場、地域別

  • 主な調査結果
  • イントロダクション
    • マイコプラズマ検査市場評価、地域別、2019年~2032年
  • マイコプラズマ検査市場 - 北米
    • 北米:マイコプラズマ検査市場、製品・サービス別、2019年~2032年
    • 北米:マイコプラズマ検査市場、エンドユーザー別、2019年~2032年
    • 北米:マイコプラズマ検査市場、用途別、2019年~2032年
    • 北米:マイコプラズマ検査市場、技術別、2019年~2032年
    • マイコプラズマ検査市場 - 米国
    • マイコプラズマ検査市場 - カナダ
  • マイコプラズマ検査市場 - 欧州
    • 欧州:マイコプラズマ検査市場、製品・サービス別、2019年~2032年
    • 欧州:マイコプラズマ検査市場、エンドユーザー別、2019年~2032年
    • 欧州:マイコプラズマ検査市場、用途別、2019年~2032年
    • 欧州:マイコプラズマ検査市場、技術別、2019年~2032年
    • マイコプラズマ検査市場 - 英国
    • マイコプラズマ検査市場 - フランス
    • マイコプラズマ検査市場 - ドイツ
    • マイコプラズマ検査市場 - イタリア
    • マイコプラズマ検査市場 - スペイン
    • マイコプラズマ検査市場 - オランダ
    • マイコプラズマ検査市場 - ロシア
  • マイコプラズマ検査市場 - アジア太平洋
    • アジア太平洋:マイコプラズマ検査市場、製品・サービス別、2019年~2032年
    • アジア太平洋:マイコプラズマ検査市場、エンドユーザー別、2019年~2032年
    • アジア太平洋:マイコプラズマ検査市場、用途別、2019年~2032年
    • アジア太平洋:マイコプラズマ検査市場、技術別、2019年~2032年
    • マイコプラズマ検査市場 - 中国
    • マイコプラズマ検査市場 - インド
    • マイコプラズマ検査市場 - 日本
    • マイコプラズマ検査市場 - マレーシア
    • マイコプラズマ検査市場 - インドネシア
    • マイコプラズマ検査市場 - 韓国
  • マイコプラズマ検査市場 - 中東・アフリカ
    • 中東・アフリカ:マイコプラズマ検査市場、製品・サービス別、2019年~2032年
    • 中東・アフリカ:マイコプラズマ検査市場、エンドユーザー別、2019年~2032年
    • 中東・アフリカ:マイコプラズマ検査市場、用途別、2019年~2032年
    • 中東・アフリカ:マイコプラズマ検査市場、技術別、2019年~2032年
    • マイコプラズマ検査市場 - サウジアラビア
    • マイコプラズマ検査市場 - 南アフリカ
    • マイコプラズマ検査市場 - イスラエル
    • マイコプラズマ検査市場 - UAE
  • マイコプラズマ検査市場 - ラテンアメリカ
    • ラテンアメリカ:マイコプラズマ検査市場、製品・サービス別、2019年~2032年
    • ラテンアメリカ:マイコプラズマ検査市場、エンドユーザー別、2019年~2032年
    • ラテンアメリカ:マイコプラズマ検査市場、用途別、2019年~2032年
    • ラテンアメリカ:マイコプラズマ検査市場、技術別、2019年~2032年
    • マイコプラズマ検査市場 - メキシコ
    • マイコプラズマ検査市場 - ブラジル
    • マイコプラズマ検査市場 - アルゼンチン

第10章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第11章 企業プロファイル

  • Agilent Technologies(US)
  • American Type Culture Collection(US)
  • Biological Industries Israel Beit Haemek Ltd.(Israel)
  • Bionique Testing Laboratories, Inc.(US)
  • Biotools B & M Labs, S.A.(Spain)
  • Charles River Laboratories International, Inc.(US)
  • Creative Bioarray(US)
  • Eurofins Scientific(Luxembourg)
  • GeneCopoeia, Inc.(US)
  • GenBio(Canada)
  • InvivoGen(US)
  • Lonza Group Ltd.(Switzerland)
  • Merck KGaA(Germany)
  • Meridian Bioscience, Inc.(US)
  • Minerva Biolabs GmbH(Germany)
図表

List of Tables

  • Table 1 Global Mycoplasma Testing Market, by Product & Service, by Region, 2019-2032 (USD Million)
  • Table 2 Global Mycoplasma Testing Market, by Application, by Region, 2019-2032 (USD Million)
  • Table 3 Global Mycoplasma Testing Market, by Technique, by Region, 2019-2032 (USD Million)
  • Table 4 Global Mycoplasma Testing Market, by End User, by Region, 2019-2032 (USD Million)
  • Table 5 Mycoplasma Testing Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 6 North America: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 7 North America: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 8 North America: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 9 North America: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 10 U.S.: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 11 U.S.: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 12 U.S.: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 13 U.S.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 14 Canada: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 15 Canada: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 16 Canada: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 17 Canada: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 18 Europe: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 19 Europe: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 20 Europe: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 21 Europe: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 22 Germany: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 23 Germany: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 24 Germany: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 25 Germany: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 26 France: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 27 France: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 28 France: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 29 France: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 30 UK: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 31 UK: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 32 UK: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 33 UK: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 34 Italy: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 35 Italy: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 36 Italy: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 37 Italy: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 38 Netherlands: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 39 Netherlands: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 40 Netherlands: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 41 Netherlands: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 42 Spain: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 43 Spain: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 44 Spain: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 45 Spain: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 46 Russia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 47 Russia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 48 Russia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 49 Russia: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 50 Asia Pacific: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 51 Asia Pacific: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 52 Asia Pacific: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 53 Asia Pacific: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 54 China: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 55 China: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 56 China: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 57 China: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 58 Japan: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 59 Japan: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 60 Japan: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 61 Japan: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 62 India: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 63 India: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 64 India: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 65 India: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 66 Indonesia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 67 Indonesia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 68 Indonesia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 69 Indonesia: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 70 Malaysia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 71 Malaysia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 72 Malaysia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 73 Malaysia: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 74 South Korea: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 75 South Korea: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 76 South Korea: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 77 South Korea: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 78 Latin America: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 79 Latin America: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 80 Latin America: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 81 Latin America: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 82 Brazil: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 83 Brazil: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 84 Brazil: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 85 Brazil: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 86 Mexico: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 87 Mexico: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 88 Mexico: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 89 Mexico: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 90 Argentina: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 91 Argentina: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 92 Argentina: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 93 Argentina: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 94 Middle East & Africa: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 95 Middle East & Africa: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 96 Middle East & Africa: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 97 Middle East & Africa: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 98 UAE: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 99 UAE: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 100 UAE: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 101 UAE: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 102 Saudi Arabia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 103 Saudi Arabia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 104 Saudi Arabia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 105 Saudi Arabia: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 106 South Africa: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 107 South Africa: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 108 South Africa: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 109 South Africa: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 110 Israel: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 111 Israel: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 112 Israel: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 113 Israel: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Mycoplasma Testing Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up End User
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product & Service
  • Figure 7. Global Mycoplasma Testing Market, by Product & Service, 2021 & 2030 (USD Million)
  • Figure 8. Market by End User
  • Figure 9. Global Mycoplasma Testing Market, by End User, 2021 & 2030 (USD Million)
  • Figure 10. Market by Application
  • Figure 11. Global Mycoplasma Testing Market, by Application, 2021 & 2030 (USD Million)
  • Figure 12. Market by Technique
  • Figure 13. Global Mycoplasma Testing Market, by Technique, 2021 & 2030 (USD Million)
目次
Product Code: PM1785

The global mycoplasma testing market size is expected to reach USD 2909.64 Million by 2032, according to a new study by Polaris Market Research. The report "Mycoplasma Testing Market Share, Size, Trends, Industry Analysis Report, By Product & Service (Assays, Kits, & Reagents, Instruments, Services); By Technique; By Application; By End User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Mycoplasma is a type of bacteria without a cell wall. It is mostly likely to affect the respiratory, urinary, and genital tracts of humans. The presence of stringent regulations and growing concerns about consumer safety is enabling pharmaceutical companies to focus on comprehensive biological testing, including testing of mycoplasma.

A 2023 study published in the Journal of Microbiology focused on exploring advancements in the detection of Mycoplasma genitalium. The recent clearance of molecular-based assays by the U.S. Food and Drug Administration (FDA) permitted diagnostic testing to be widely employed in the United States, making it no longer available only in some laboratories. This is positively influencing the growth of the mycoplasma market.

The emergence of antimicrobial resistance made it difficult to test the presence of mycoplasma in pharmaceutical products and services, which fueled the development of diagnostic tests to determine resistance. Mycoplasma is mostly found in the production phase of biopharmaceutical products, including from the research stage to clinical development, highlighting the need for mycoplasma testing to check safety and accuracy in treating certain diseases.

The growing research innovations in this field and the adoption of advanced technologies are anticipated to promote the expansion of the mycoplasma testing market. For instance, in November 2023, QIAGEN unveiled its three new QIAcuity kits and software update to expand its product line for polymerase chain reaction technology in cell and gene therapies, the food industry, and the pharmaceutical industry.

Ongoing expansion activities by biopharmaceutical companies to enhance the quality and safety of their products are positively influencing the mycoplasma testing market. For instance, in November 2023, Bionique, a pharmaceutical lab specializing in protecting medicines from bacteria, expanded its location at Lake Clear, New York, to meet ongoing demand from rapidly growing cell and gene therapies in the region.

Mycoplasma Testing Market Report Highlights

Assays, Kits, & reagents segment is anticipated to witness the highest growth in the coming years due to the need for ready-to-test kits.

NAT segment accounted for the largest market share owing to its capability to offer faster results.

Cell line testing segment is projected to experience a larger revenue share due to growing biopharmaceutical production.

Asia Pacific is projected to register the fastest growth during the forecast period, attributable to the rising innovations in cell and gene therapies.

The global players include Agilent Technologies, American Type Culture Collection, Biological Industries Israel Beit Haemek Ltd, & Bionique Testing Laboratories, Inc.

Polaris Market Research has segmented the mycoplasma testing market report based on product & service, technique, application, end user and region:

Mycoplasma Testing, Product & Service Outlook (Revenue - USD Million, 2019 - 2032)

  • Assays, Kits, & Reagents
  • NAT assays, kits, & reagents
  • ELISA assays, kits, & reagents
  • Elimination Kits
  • Stains
  • Other assays, kits, & reagents
  • Instruments
  • Services

Mycoplasma Testing, Technique Outlook (Revenue - USD Million, 2019 - 2032)

  • NAT
  • ELISA
  • Staining
  • Other technique

Mycoplasma Testing, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Cell line testing
  • Virus Testing
  • End-of-Production cell testing

Mycoplasma Testing, End User Outlook (Revenue - USD Million, 2019 - 2032)

  • Pharmaceutical & Biotechnology Companies
  • Cell Banks & Laboratories
  • Contract Research Organizations
  • Academic Research Institutes

Mycoplasma Testing, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Mycoplasma Testing Market Insights

  • 4.1. Mycoplasma Testing - Industry Snapshot
  • 4.2. Mycoplasma Testing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising research studies exploring mycoplasma detection
      • 4.2.1.2. The growing incidence of mycoplasma-related health issues
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. The researchers' resistance in adopting new innovations
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Mycoplasma Testing Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Mycoplasma Testing Market, by Product & Service

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • 5.3. Assays, Kits, & Reagents
    • 5.3.1. Global Mycoplasma Testing Market, by Assays, Kits, & Reagents, by Region, 2019-2032 (USD Million)
    • 5.3.2. NAT assays, kits, & reagents
      • 5.3.2.1. Global Mycoplasma Testing Market, by NAT assays, kits, & reagents, by Region, 2019-2032 (USD Million)
    • 5.3.3. ELISA assays, kits, & reagents
      • 5.3.3.1. Global Mycoplasma Testing Market, by ELISA assays, kits, & reagents, by Region, 2019-2032 (USD Million)
    • 5.3.4. Elimination Kits
      • 5.3.4.1. Global Mycoplasma Testing Market, by Elimination Kits, by Region, 2019-2032 (USD Million)
    • 5.3.5. Stains
      • 5.3.5.1. Global Mycoplasma Testing Market, by Stains, by Region, 2019-2032 (USD Million)
    • 5.3.6. Other assays, kits, & reagents
      • 5.3.6.1. Global Mycoplasma Testing Market, by Other assays, kits, & reagents, by Region, 2019-2032 (USD Million)
  • 5.4. Instruments
    • 5.4.1. Global Mycoplasma Testing Market, by Instruments, by Region, 2019-2032 (USD Million)
  • 5.5. Services
    • 5.5.1. Global Mycoplasma Testing Market, by Services, by Region, 2019-2032 (USD Million)

6. Global Mycoplasma Testing Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • 6.3. Cell line testing
    • 6.3.1. Global Mycoplasma Testing Market, by Cell line testing, by Region, 2019-2032 (USD Million)
  • 6.4. Virus Testing
    • 6.4.1. Global Mycoplasma Testing Market, by Virus Testing, by Region, 2019-2032 (USD Million)
  • 6.5. End-of-Production cell testing
    • 6.5.1. Global Mycoplasma Testing Market, by End-of-Production cell testing, by Region, 2019-2032 (USD Million)

7. Global Mycoplasma Testing Market, by Technique

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • 7.3. NAT
    • 7.3.1. Global Mycoplasma Testing Market, by NAT, by Region, 2019-2032 (USD Million)
  • 7.4. ELISA
    • 7.4.1. Global Mycoplasma Testing Market, by ELISA, by Region, 2019-2032 (USD Million)
  • 7.5. Staining
    • 7.5.1. Global Mycoplasma Testing Market, by Staining, by Region, 2019-2032 (USD Million)
  • 7.6. Other technique
    • 7.6.1. Global Mycoplasma Testing Market, by Other technique, by Region, 2019-2032 (USD Million)

8. Global Mycoplasma Testing Market, by End User

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • 8.3. Pharmaceutical & Biotechnology Companies
    • 8.3.1. Global Mycoplasma Testing Market, by Pharmaceutical & Biotechnology Companies, by Region, 2019-2032 (USD Million)
  • 8.4. Cell Banks & Laboratories
    • 8.4.1. Global Mycoplasma Testing Market, by Cell Banks & Laboratories, by Region, 2019-2032 (USD Million)
  • 8.5. Contract Research Organizations
    • 8.5.1. Global Mycoplasma Testing Market, by Contract Research Organizations, by Region, 2019-2032 (USD Million)
  • 8.6. Academic Research Institutes
    • 8.6.1. Global Mycoplasma Testing Market, by Academic Research Institutes, by Region, 2019-2032 (USD Million)

9. Global Mycoplasma Testing Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Mycoplasma Testing Market Assessment, By Geography, 2019-2032 (USD Million)
  • 9.3. Mycoplasma Testing Market - North America
    • 9.3.1. North America: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
    • 9.3.2. North America: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
    • 9.3.3. North America: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
    • 9.3.4. North America: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.3.5. Mycoplasma Testing Market - U.S.
      • 9.3.5.1. U.S.: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.3.5.2. U.S.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.3.5.3. U.S.: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.3.5.4. U.S.: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.3.6. Mycoplasma Testing Market - Canada
      • 9.3.6.1. Canada: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.3.6.2. Canada: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.3.6.3. Canada: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.3.6.4. Canada: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • 9.4. Mycoplasma Testing Market - Europe
    • 9.4.1. Europe: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
    • 9.4.2. Europe: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
    • 9.4.3. Europe: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
    • 9.4.4. Europe: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.5. Mycoplasma Testing Market - UK
      • 9.4.5.1. UK: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.5.2. UK: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.5.3. UK: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.5.4. UK: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.6. Mycoplasma Testing Market - France
      • 9.4.6.1. France: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.6.2. France: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.6.3. France: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.6.4. France: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.7. Mycoplasma Testing Market - Germany
      • 9.4.7.1. Germany: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.7.2. Germany: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.7.3. Germany: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.7.4. Germany: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.8. Mycoplasma Testing Market - Italy
      • 9.4.8.1. Italy: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.8.2. Italy: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.8.3. Italy: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.8.4. Italy: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.9. Mycoplasma Testing Market - Spain
      • 9.4.9.1. Spain: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.9.2. Spain: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.9.3. Spain: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.9.4. Spain: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.10. Mycoplasma Testing Market - Netherlands
      • 9.4.10.1. Netherlands: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.10.2. Netherlands: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.10.3. Netherlands: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.10.4. Netherlands: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.11. Mycoplasma Testing Market - Russia
      • 9.4.11.1. Russia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.11.2. Russia.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.11.3. Russia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.11.4. Russia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • 9.5. Mycoplasma Testing Market - Asia Pacific
    • 9.5.1. Asia Pacific: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
    • 9.5.2. Asia Pacific: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
    • 9.5.3. Asia Pacific: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
    • 9.5.4. Asia Pacific: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.5.5. Mycoplasma Testing Market - China
      • 9.5.5.1. China: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.5.2. China.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.5.5.3. China: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.5.5.4. China: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.5.6. Mycoplasma Testing Market - India
      • 9.5.6.1. India: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.6.2. India.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.5.6.3. India: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.5.6.4. India: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.5.7. Mycoplasma Testing Market - Japan
      • 9.5.7.1. Japan: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.7.2. Japan.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.5.7.3. Japan: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.5.7.4. Japan: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.5.8. Mycoplasma Testing Market - Malaysia
      • 9.5.8.1. Malaysia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.8.2. Malaysia.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.5.8.3. Malaysia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.5.8.4. Malaysia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.5.9. Mycoplasma Testing Market - Indonesia
      • 9.5.9.1. Indonesia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.9.2. Indonesia.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.5.9.3. Indonesia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.5.9.4. Indonesia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.5.10. Mycoplasma Testing Market - South Korea
      • 9.5.10.1. South Korea: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.10.2. South Korea.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.5.10.3. South Korea: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.5.10.4. South Korea: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • 9.6. Mycoplasma Testing Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
    • 9.6.2. Middle East & Africa: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
    • 9.6.3. Middle East & Africa: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
    • 9.6.4. Middle East & Africa: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.6.5. Mycoplasma Testing Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.6.5.2. Saudi Arabia: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.6.5.3. Saudi Arabia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.6.5.4. Saudi Arabia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.6.6. Mycoplasma Testing Market - South Africa
      • 9.6.6.1. South Africa: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.6.6.2. South Africa: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.6.6.3. South Africa: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.6.6.4. South Africa: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.6.7. Mycoplasma Testing Market - Israel
      • 9.6.7.1. Israel: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.6.7.2. Israel: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.6.7.3. Israel: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.6.7.4. Israel: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.6.8. Mycoplasma Testing Market - UAE
      • 9.6.8.1. UAE: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.6.8.2. UAE: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.6.8.3. UAE: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.6.8.4. UAE: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • 9.7. Mycoplasma Testing Market - Latin America
    • 9.7.1. Latin America: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
    • 9.7.2. Latin America: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
    • 9.7.3. Latin America: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
    • 9.7.4. Latin America: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.7.5. Mycoplasma Testing Market - Mexico
      • 9.7.5.1. Mexico: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.7.5.2. Mexico: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.7.5.3. Mexico: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.7.5.4. Mexico: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.7.6. Mycoplasma Testing Market - Brazil
      • 9.7.6.1. Brazil: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.7.6.2. Brazil: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.7.6.3. Brazil: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.7.6.4. Brazil: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.7.7. Mycoplasma Testing Market - Argentina
      • 9.7.7.1. Argentina: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.7.7.2. Argentina: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.7.7.3. Argentina: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.7.7.4. Argentina: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Agilent Technologies (US)
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. American Type Culture Collection (US)
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Biological Industries Israel Beit Haemek Ltd. (Israel)
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Bionique Testing Laboratories, Inc. (US)
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Biotools B & M Labs, S.A. (Spain)
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Charles River Laboratories International, Inc. (US)
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Creative Bioarray (US)
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Eurofins Scientific (Luxembourg)
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. GeneCopoeia, Inc. (US)
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. GenBio (Canada)
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. InvivoGen (US)
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Lonza Group Ltd. (Switzerland)
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Merck KGaA (Germany)
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Meridian Bioscience, Inc. (US)
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Minerva Biolabs GmbH (Germany)
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development